Works matching IS 14501147 AND DT 2020 AND VI 19 AND IP 1


Results: 19
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Potential application of lutetium-177-labeled prostate-specific membrane antigen-617 radioligand therapy for metastatic castration-resistant prostate cancer in a limited resource environment: Initial clinical experience after 2 years.

    Published in:
    World Journal of Nuclear Medicine, 2020, v. 19, n. 1, p. 15, doi. 10.4103/wjnm.WJNM_20_19
    By:
    • Assadi, Majid;
    • Rezaei, Samira;
    • Jafari, Esmail;
    • Rekabpour, Seyed;
    • Ravanbod, Mohammad;
    • Zohrabi, Farshad;
    • Amini, AbdulLatif;
    • Keshmiri, Saeid;
    • Dadgar, Habibollah;
    • Ahmadzadehfar, Hojjat
    Publication type:
    Article
    19